Vol. 32 No. 11 2004
■ ROUNDTABLE DISCUSSION
Latest findings on the prevention of cardiovascular events
─Focus on the AT1 receptor─
Issei Komuro/Shinichiro Miura/Yunzeng Zou
Jpn Pharmacol Ther 2004 32(11) 751-8
■ ORIGINAL ARTICLES
Antihypertensive effect of an aqueous extract powder from Mycoleptodonoides aitchisonii in
high-normal and mild hypertensive (low-medium risk) group
T. Sato, et al.
Jpn Pharmacol Ther 2004 32(11) 761-71
The long-term safety evaluation of excessive an aqueous extract powder
from Mycoleptodonoides aitchisonii in high-normal blood pressure
T. Sato, et al.
Jpn Pharmacol Ther 2004 32(11) 773-9
Ameliorative effects of sarpogrelate alone or combined with
Lipo PGE1 on decreased dermal blood flow in rat hindpaw ischemia model
T. Akira, et al.
Jpn Pharmacol Ther 2004 32(11) 781-6
Pharmaological characterization of indisetron hydrochloride,
as a novel 5-HT3 receptor antagonist
S. Taniguchi, et al.
Jpn Pharmacol Ther 2004 32(11) 789-97
The inhibitory action of indisetron hydrochloride, a 5-HT3 receptor antagonist,
against the anticancer drug-induced emesis in the dog, ferret and suncus
S. Taniguchi, et al.
Jpn Pharmacol Ther 2004 32(11) 799-806
Pharmacokinetics and safety of indisetron tablets in healthy subjects
─Single oral dose study─
T. Yamada, et al.
Jpn Pharmacol Ther 2004 32(11) 807-13
Pharmacokinetics and safety of indisetron tablets in healthy subjects
─Multiple-oral dose study─
T. Yamada, et al.
Jpn Pharmacol Ther 2004 32(11) 815-21
Clinical efficacy and safety profile of indisetron tablets
in prevention of nausea and vomiting induced by chemotherapy including cisplatin
─Phase II dose finding study─
H. Niitani, et al.
Jpn Pharmacol Ther 2004 32(11) 823-38
Clinical efficacy and safety profile of indisetron tablets
in prevention of nausea and vomiting induced by chemotherapy including cisplatin
─Double-blind randomized controlled trialwith ondansetron tablets─
N. Nukariya, et al.
Jpn Pharmacol Ther 2004 32(11) 839-53
Clinical efficacy and safety profile of Indisetron tablets in prevention of nausea and
vomiting induced by various anti-cancer drugs excluding cisplatin
N. Nukariya, et al.
Jpn Pharmacol Ther 2004 32(11) 855-65
Pharmacokinetics and safety of indisetron tablets in patientes treated by chemotherapy
─Single oral dose study─
N. Nukariya, et al.
Jpn Pharmacol Ther 2004 32(11) 867-75
